DBV Technologies (DBVT) Common Equity (2015 - 2026)
DBV Technologies (DBVT) reported Common Equity of $207.9 million for Q1 2026, up 7068.97% year-over-year from $2.9 million in Q1 2025, and up 23.16% quarter-over-quarter from $168.8 million in Q4 2025.
DBV Technologies (DBVT) Common Equity (2015 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 12 years of Common Equity data on file, last reported at $207.9 million in Q1 2026.
- Common Equity for Q1 2026 came in at $207.9 million, up 7068.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $207.9 million (up 7068.97% YoY), and the FY2025 annual result was $168.8 million, up 516.06% from the prior year.
- Common Equity grew to $207.9 million in Q1 2026 per DBVT's latest filing, from $168.8 million in the prior quarter.
- Over five years, Common Equity peaked at $244.4 million in Q2 2022 and troughed at $2.9 million in Q1 2025.
- A 5-year average of $126.6 million and a median of $140.2 million in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2025 and 2026: Common Equity tumbled 97.4% in 2025, then soared 7068.97% in 2026.
- A 5-year view of Common Equity shows it stood at $194.5 million in 2022, then declined by 27.91% to $140.2 million in 2023, then plunged by 80.45% to $27.4 million in 2024, then soared by 516.06% to $168.8 million in 2025, then rose by 23.16% to $207.9 million in 2026.
- Business Quant data shows DBVT's Common Equity at $207.9 million in Q1 2026, $168.8 million in Q4 2025, and $52.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | 207.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 207.90 Mn |
| Dec 31, 2025 | 168.80 Mn |
| Sep 30, 2025 | 52.85 Mn |
| Jun 30, 2025 | 86.22 Mn |
| Mar 31, 2025 | 2.90 Mn |
| Dec 31, 2024 | 27.40 Mn |
| Sep 30, 2024 | 54.03 Mn |
| Jun 30, 2024 | 79.10 Mn |
| Mar 31, 2024 | 111.65 Mn |
| Dec 31, 2023 | 140.19 Mn |
| Sep 30, 2023 | 143.99 Mn |
| Jun 30, 2023 | 164.24 Mn |
| Mar 31, 2023 | 179.09 Mn |
| Dec 31, 2022 | 194.45 Mn |
| Sep 30, 2022 | 212.05 Mn |
| Jun 30, 2022 | 244.42 Mn |
| Mar 31, 2022 | 82.06 Mn |
| Dec 31, 2021 | 99.27 Mn |
| Sep 30, 2021 | 116.89 Mn |
| Jun 30, 2021 | 143.02 Mn |